Sort by
Previous Page Page 2 of 11 Next Page
  1. Research

    Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST segment elevation myocardial infarction (FAMOUS-NSTEMI) developmental trial: cost-effectiveness using a mixed trial- and model-based methods

    In the Fractional flow reserve (FFR) versus angiography in guiding management to optimise outcomes in non-ST elevation myocardial infarction (FAMOUS) clinical trial, FFR was shown to significantly reduce coro...

    Julian Nam, Andrew Briggs, Jamie Layland, Keith G. Oldroyd, Nick Curzen, Arvind Sood, Kanarath Balachandran, Raj Das, Shahid Junejo, Hany Eteiba, Mark C. Petrie, Mitchell Lindsay, Stuart Watkins, Simon Corbett, Brian O’Rourke, Anna O’Donnell…

    Cost Effectiveness and Resource Allocation 2015 13:19

    Published on: 14 November 2015

  2. Research

    Impact on total population health and societal cost, and the implication on the actual cost-effectiveness of including tumour necrosis factor-α antagonists in management of ankylosing spondylitis: a dynamic population modelling study

    Sequential treatment of ankylosing spondylitis (AS) that includes tumour necrosis factor-α antagonists (anti-TNF agents) has been applied in most of the Western countries. Existing cost-effectiveness (CE) mode...

    An Tran-Duy, Annelies Boonen, Mart A. F. J. van de Laar and Johan L. Severens

    Cost Effectiveness and Resource Allocation 2015 13:18

    Published on: 7 October 2015

  3. Research

    New all oral therapy for chronic hepatitis C virus (HCV): a novel long-term cost comparison

    In the US, the prevalence of hepatitis C virus (HCV) has surpassed the prevalence of human immunodeficiency virus (HIV), with about 3.3 million people chronically infected with the disease. Given the aging of ...

    Jennifer M. Poonsapaya, Michael Einodshofer, Heather S. Kirkham, Pheophilus Glover and Janeen DuChane

    Cost Effectiveness and Resource Allocation 2015 13:17

    Published on: 6 October 2015

  4. Research

    Matching comprehensive health insurance reimbursements to their real costs: the case of antenatal care visits in a region of Peru

    Prepaid contributory systems are increasingly being recognized as key mechanisms in achieving universal health coverage in low and middle-income countries. Peru created the Seguro Integral de Salud (SIS) to in...

    Daniel Cobos Muñoz, Kristian Schultz Hansen, Fern Terris-Prestholt, Fiona Cianci, José Enrique Pérez-Lu, Aldo Lama and Patricia J. García

    Cost Effectiveness and Resource Allocation 2015 13:16

    Published on: 19 September 2015

  5. Research

    Is chest X-ray screening for lung cancer in smokers cost-effective? Evidence from a population-based study in Italy

    After implementation of the PREDICA annual chest X-ray (CXR) screening program in smokers in the general practice setting of Varese-Italy a significant reduction in lung cancer-specific mortality (18 %) was ob...

    Paolo Pertile, Albino Poli, Lorenzo Dominioni, Nicola Rotolo, Elisa Nardecchia, Massimo Castiglioni, Massimo Paolucci, William Mantovani and Andrea Imperatori

    Cost Effectiveness and Resource Allocation 2015 13:15

    Published on: 12 September 2015

  6. Research

    Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden

    Tiotropium (TIO) is a well-established bronchodilator, LAMA (long-acting anticholinergic), for the treatment of moderate to very severe chronic obstructive pulmonary disease (COPD). Clinical evidence suggests ...

    Oskar Eklund, Faraz Afzal and Fredrik Borgström

    Cost Effectiveness and Resource Allocation 2015 13:13

    Published on: 19 August 2015

  7. Research

    Validation of the UKPDS 82 risk equations within the Cardiff Diabetes Model

    For end-users of diabetes models that include UKPDS 82 risk equations, an important question is how well these new equations perform. Consequently, the principal objective of this study was to validate the UKP...

    Philip McEwan, Thomas Ward, Hayley Bennett and Klas Bergenheim

    Cost Effectiveness and Resource Allocation 2015 13:12

    Published on: 4 August 2015

  8. Research

    Cost-utility analysis of certolizumab pegol versus alternative tumour necrosis factor inhibitors available for the treatment of moderate-to-severe active rheumatoid arthritis in Spain

    Certolizumab pegol, a PEGylated tumour necrosis factor (TNF)-inhibitor, improves the clinical signs and symptoms of rheumatoid arthritis (RA) when used in combination with methotrexate or as monotherapy. This ...

    Álvaro Hidalgo-Vega, Renata Villoro, Juan Antonio Blasco, Pablo Talavera, Belén Ferro and Oana Purcaru

    Cost Effectiveness and Resource Allocation 2015 13:11

    Published on: 9 June 2015

  9. Research

    Economic evaluation of a single-pill triple antihypertensive therapy with valsartan, amlodipine, and hydrochlorothiazide against its dual components

    The aim of this study was to compare the cost-utility of the first available single-pill triple combination antihypertensive therapy containing valsartan (V), amlodipine (A) and hydrochlorothiazide (H), with e...

    Panagiotis Stafylas, Georgia Kourlaba, Magda Hatzikou, Dimitrios Georgiopoulos, Pantelis Sarafidis and Nikolaos Maniadakis

    Cost Effectiveness and Resource Allocation 2015 13:10

    Published on: 9 June 2015

  10. Research

    Cost-effectiveness of live oral attenuated human rotavirus vaccine in Tanzania

    Globally, diarrhoea is the second leading cause of morbidity and mortality, responsible for the annual loss of about 10% of the total global childhood disease burden. In Tanzania, Rotavirus infection is the ma...

    George M Ruhago, Frida N Ngalesoni, Bjarne Robberstad and Ole F Norheim

    Cost Effectiveness and Resource Allocation 2015 13:7

    Published on: 28 April 2015

  11. Research

    The determinants of technical efficiency of a large scale HIV prevention project: application of the DEA double bootstrap using panel data from the Indian Avahan

    In 2004, the largest HIV prevention project (Avahan) conducted globally was implemented in India. Avahan was implemented by NGOs supported by state lead partners in order to provide HIV prevention services to ...

    Aurélia Lépine, Anna Vassall and Sudhashree Chandrashekar

    Cost Effectiveness and Resource Allocation 2015 13:5

    Published on: 29 March 2015

  12. Research

    Revisiting the cost-effectiveness of universal HPV-vaccination in Denmark accounting for all potentially vaccine preventable HPV-related diseases in males and females

    The purpose of this study was to assess the consequences of a national immunization program with HPV vaccine for both boys and girls in Denmark, including the prophylactic effects on all potentially vaccine pr...

    Jens Olsen and Tine Rikke Jørgensen

    Cost Effectiveness and Resource Allocation 2015 13:4

    Published on: 11 February 2015

  13. Research

    Cost-effectiveness of using a social franchise network to increase uptake of oral rehydration salts and zinc for childhood diarrhea in rural Myanmar

    This paper examines the cost-effectiveness of achieving increases in the use of oral rehydration solution and zinc supplementation in the management of acute diarrhea in children under 5 years through social f...

    David Bishai, Karampreet Sachathep, Amnesty LeFevre, Hnin New Nwe Thant, Min Zaw, Tin Aung, Willi McFarland and Dominic Montagu

    Cost Effectiveness and Resource Allocation 2015 13:3

    Published on: 5 February 2015

  14. Research

    An approach to prioritization of medical devices in low-income countries: an example based on the Republic of South Sudan

    Efficient and evidence-based medical device and equipment prioritization is of particular importance in low-income countries due to constraints in financing capacity, physical infrastructure and human resource...

    Richard J Lilford, Samantha L Burn, Karin D Diaconu, Peter Lilford, Peter J Chilton, Victoria Bion, Carole Cummins and Semira Manaseki-Holland

    Cost Effectiveness and Resource Allocation 2015 13:2

    Published on: 10 January 2015

  15. Research

    Cost-effectiveness and affordability of community mobilisation through women’s groups and quality improvement in health facilities (MaiKhanda trial) in Malawi

    Understanding the cost-effectiveness and affordability of interventions to reduce maternal and newborn deaths is critical to persuading policymakers and donors to implement at scale. The effectiveness of commu...

    Tim Colbourn, Anni-Maria Pulkki-Brännström, Bejoy Nambiar, Sungwook Kim, Austin Bondo, Lumbani Banda, Charles Makwenda, Neha Batura, Hassan Haghparast-Bidgoli, Rachael Hunter, Anthony Costello, Gianluca Baio and Jolene Skordis-Worrall

    Cost Effectiveness and Resource Allocation 2015 13:1

    Published on: 10 January 2015

  16. Research

    Do the Washington Panel recommendations hold for Europe: investigating the relation between quality of life versus work-status, absenteeism and presenteeism

    The question of how to value lost productivity in economic evaluations has been subject of debate in the past twenty years. According to the Washington panel, lost productivity influences health-related qualit...

    Saskia Knies, Annelies Boonen and Johan L Severens

    Cost Effectiveness and Resource Allocation 2014 12:24

    Published on: 24 November 2014

  17. Review

    Health research priority setting in selected high income countries: a narrative review of methods used and recommendations for future practice

    Research priority setting aims to gain consensus about areas where research effort will have wide benefits to society. While general principles for setting health research priorities have been suggested, there...

    Jamie Bryant, Rob Sanson-Fisher, Justin Walsh and Jessica Stewart

    Cost Effectiveness and Resource Allocation 2014 12:23

    Published on: 18 November 2014

  18. Research

    Does technique matter; a pilot study exploring weighting techniques for a multi-criteria decision support framework

    There is an increased interest in the use of multi-criteria decision analysis (MCDA) to support regulatory and reimbursement decision making. The EVIDEM framework was developed to provide pragmatic multi-crite...

    Janine van Til, Catharina Groothuis-Oudshoorn, Marijke Lieferink, James Dolan and Mireille Goetghebeur

    Cost Effectiveness and Resource Allocation 2014 12:22

    Published on: 18 November 2014

Previous Page Page 2 of 11 Next Page